share_log

12 Health Care Stocks Moving In Tuesday's Intraday Session

Benzinga ·  Mar 20 01:31

Gainers

  • Ontrak (NASDAQ:OTRK) shares increased by 97.6% to $0.38 during Tuesday's regular session. The market value of their outstanding shares is at $10.3 million.
  • Fusion Pharmaceuticals (NASDAQ:FUSN) stock moved upwards by 97.41% to $21.0. The company's market cap stands at $1.5 billion.
  • SCWorx (NASDAQ:WORX) stock rose 70.74% to $3.21. The market value of their outstanding shares is at $3.8 million.
  • Enliven Therapeutics (NASDAQ:ELVN) stock increased by 29.19% to $16.33. The company's market cap stands at $675.2 million. The company's, Q4 earnings came out 3 days ago.
  • Vincerx Pharma (NASDAQ:VINC) stock rose 28.31% to $6.3. The market value of their outstanding shares is at $134.6 million.
  • NKGen Biotech (NASDAQ:NKGN) shares moved upwards by 26.9% to $2.5. The market value of their outstanding shares is at $54.7 million.

Losers

  • Acutus Medical (NASDAQ:AFIB) stock declined by 26.5% to $0.19 during Tuesday's regular session. The market value of their outstanding shares is at $5.6 million.
  • Seelos Therapeutics (NASDAQ:SEEL) stock fell 25.91% to $0.68. The market value of their outstanding shares is at $9.3 million.
  • Lantern Pharma (NASDAQ:LTRN) stock declined by 19.38% to $8.03. The company's market cap stands at $86.2 million. As per the news, the Q4 earnings report came out yesterday.
  • Eyenovia (NASDAQ:EYEN) stock fell 18.31% to $1.25. The company's market cap stands at $55.1 million. As per the news, the Q4 earnings report came out yesterday.
  • Genprex (NASDAQ:GNPX) stock decreased by 16.88% to $3.4. The market value of their outstanding shares is at $5.0 million.
  • Acurx Pharmaceuticals (NASDAQ:ACXP) stock decreased by 15.84% to $2.18. The company's market cap stands at $30.0 million. As per the press release, Q4 earnings came out yesterday.

This article was generated by Benzinga's automated content engine and reviewed by an editor.

The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
    Write a comment